Phillyrin alleviates high glucose-induced oxidative stress and inflammation in HBZY-1 cells through inhibition of the PI3K/Akt signaling pathway
Article in Journal of Pharmacy and Pharmacology (March 2024)
The most recent citing publications are shown below. View all 54 publications that cite this research output on Dimensions.
Article in Journal of Pharmacy and Pharmacology (March 2024)
Article in Cell Death Discovery (February 2024)
Preprint in bioRxiv (January 2024)